Total Clarity Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,500
Closed -$33K 311
2022
Q2
$33K Buy
+1,500
New +$30.3K 0.02% 477

Other funds holding BTAL

Total Clarity Wealth Management's BTAL Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2022, closing a stake of 1,500 shares — an estimated $33K sold.

Total Clarity Wealth Management first reported a position in BTAL in Q2 2022 and held it in 1 quarter. The position peaked at $33K in Q2 2022. 63 funds tracked by Wall St. Rank hold BTAL as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 1,500 AGF US Market Neutral Anti-Beta Fund shares in Q3 2022, an estimated $33K.
  • Total Clarity Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2022 and held it in 1 quarter.
  • Total Clarity Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $33K in Q2 2022.
  • 63 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.